RecallRadar

FDA Drug recall D-0012-2021

Cephalexin for Oral Suspension, USP 125 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-…

On 2020-09-16 the FDA classified a Class II recall of Cephalexin for Oral Suspension, USP 125 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-… by Teva Pharmaceuticals Usa, citing CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0012-2021
ClassificationClass II
Statusterminated
Initiated2020-08-24
Published2020-09-16
Last updated2026-09-13 11:52 UTC
CompanyTeva Pharmaceuticals Usa
DistributionUS

Product

Cephalexin for Oral Suspension, USP 125 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-4175-73, b) 200 mL bottle when mixed, NDC 0093-4175-74, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.

Reason

CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

Identifiers

ndc0093-3145-01
ndc0093-3145-05
ndc0093-3147-01
ndc0093-3147-05
ndc0093-4175-73
ndc0093-4175-74
ndc0093-4177-73
ndc0093-4177-74
code_info
Lot #s: a) 30309820A, Exp. 08/2020; 30310000B, 30310001B, Exp. 10/2020; 30310096A Exp. 01/2021; 30310228A, Exp. 03/2021…Lot #s: a) 30309820A, Exp. 08/2020; 30310000B, 30310001B, Exp. 10/2020; 30310096A Exp. 01/2021; 30310228A, Exp. 03/2021; 30310313A, Exp. 06/2021; b) 30309861A, Exp. 08/2020; 30310335A, Exp. 06/2021.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0012-2021%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.